Affiliation:
1. Master OMPT, University of Bologna , Bologna, Emilia-Romagna 40138, Italy
Abstract
ABSTRACT
Primary Raynaud’s phenomenon (PRP) is characterised by episodic, reversible, and disabling vasospasms of the peripheral arteries. In the most severe cases, it can lead to ulceration of the fingers and toes. Neuro fascial VascularTraining (NFVT) is a novel therapeutic approach for treating PRP. NFVT aims to enhance peripheral circulation and stimulate the autonomic nervous system (ANS) by engaging multiple physiological mechanisms simultaneously. This integrated approach works to reduce vasospasms and alleviate associated symptoms through neurodynamic and myofascial interventions. A 54-year-old woman, who has experienced pain and hypoesthesia in her hands for 9 years, received a diagnosis of PRP without systemic sclerosis in 2014. The patient reported daily colour changes in her fingers, along with pain and a temporary decrease in tactile sensitivity. The patient engaged in ten 30-minute exercise sessions, and the clinical outcomes were assessed based on several parameters. These included the frequency and duration of vasospastic attacks, evaluated using the Raynaud Condition Score, as well as pain and tingling, measured through the daily Numeric Rating Scale. The Composite Autonomic Symptom Score (COMPASS 31) was utilised to assess dysautonomia, while the frequency of medication use and the Disabilities of the Arm, Shoulder, and Hand questionnaire were also considered. The results indicated a significant improvement in symptoms. NFVT improved symptoms and motor dysfunction in a patient with Raynaud’s syndrome, demonstrating how NFVT can increase peripheral blood flow, stimulate the ANS, and improve symptoms in PRP.
Publisher
Oxford University Press (OUP)
Reference48 articles.
1. Computerized nailfold video capillaroscopy—a new tool for assessment of Raynaud’s phenomenon;Anderson;J Rheumatol,2005
2. Clinical practice. Raynaud’s Phenomenon;Wigley;N Engl J Med,2002
3. Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison;Maricq;J Rheumatol,1997
4. Raynaud’s phenomenon in older adults: diagnostic considerations and management;Ling;Drugs Aging,1999
5. A review of Raynaud’s disease;Temprano;Mo Med,2016